---
title: "YISHENG: Pledge and release of partial shares by the controlling shareholder"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260398307.md"
description: "Shandong YISHENG Animal Husbandry Co., Ltd. announced that its controlling shareholder, Cao Jisheng, recently handled partial share pledges and releases. On September 29, 15.35 million shares were pledged, accounting for 3.40% of his holdings; on September 30, 20.05 million shares were released from pledge, accounting for 4.44% of his holdings. As of the announcement date, Cao Jisheng had cumulatively pledged 194.11 million shares, accounting for 42.98% of his holdings. The company stated that the pledge risk is controllable and does not affect control and operations"
datetime: "2025-10-09T08:36:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260398307.md)
  - [en](https://longbridge.com/en/news/260398307.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260398307.md)
generator: "portal-rs"
---

# YISHENG: Pledge and release of partial shares by the controlling shareholder

Recently, Shandong Yisheng Livestock Breeding Co., Ltd. announced that its controlling shareholder and actual controller, Cao Jisheng, has conducted partial share pledges and releases. On September 29, Cao Jisheng pledged 15.35 million shares, accounting for 3.40% of his holdings and 1.39% of the total share capital, to replace previous pledged financing; on September 30, he released 20.05 million shares, accounting for 4.44% of his holdings and 1.81% of the total share capital. As of the announcement date, Cao Jisheng has cumulatively pledged 194.11 million shares, accounting for 42.98% of his holdings. The company stated that the controlling shareholder has the ability to repay, the pledge risk is controllable, and it will not affect the company's control and production operations

### Related Stocks

- [002458.CN](https://longbridge.com/en/quote/002458.CN.md)

## Related News & Research

- [Tianqi Lithium files HKEX next-day disclosure return on share repurchase, cancellation at RMB 16.71](https://longbridge.com/en/news/296486555.md)
- [12:10 ET10,000 COREWELL HEALTH EAST NURSES RATIFY FIRST TEAMSTERS CONTRACT](https://longbridge.com/en/news/296516959.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Ximei Resources clarifies tantalum pricing mechanism in Ganfeng Lithium procurement deal](https://longbridge.com/en/news/296362749.md)
- [Innovobot IRV joins Evara pre-seed financing round](https://longbridge.com/en/news/296527323.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**